Clough Capital Partners’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-64,480
Closed -$964K 126
2023
Q4
$964K Sell
64,480
-200,450
-76% -$2.91M 0.11% 108
2023
Q3
$3.84M Sell
264,930
-230,600
-47% -$3.45M 0.41% 65
2023
Q2
$7.56M Buy
495,530
+13,500
+3% +$203K 0.76% 47
2023
Q1
$7.3M Buy
482,030
+73,330
+18% +$1.09M 0.79% 45
2022
Q4
$5.67M Buy
+408,700
New +$5.77M 0.57% 61

Other funds holding BCAT

Clough Capital Partners's BCAT Position: Q1 2024 in Review

Clough Capital Partners sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q1 2024, closing a stake of 64,480 shares — an estimated $964K sold.

Clough Capital Partners first reported a position in BCAT in Q4 2022 and held it in 5 quarters. The position peaked at $7.56M in Q2 2023. 92 funds tracked by Wall St. Rank hold BCAT as of Q1 2024.

  • Clough Capital Partners reported no remaining BlackRock Capital Allocation Term Trust position as of Q1 2024 after selling out during the quarter.
  • Clough Capital Partners sold 64,480 BlackRock Capital Allocation Term Trust shares in Q1 2024, an estimated $964K.
  • Clough Capital Partners first reported a position in BlackRock Capital Allocation Term Trust in Q4 2022 and held it in 5 quarters.
  • Clough Capital Partners's BlackRock Capital Allocation Term Trust position peaked at $7.56M in Q2 2023.
  • 92 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2024.

Based on Clough Capital Partners's 13F filing for Q1 2024, filed 15 May 2024.